Sympathetic skin responses are decreased and lymphocyte beta‐adrenergic receptors are increased in progressive multiple sclerosis

JW Karaszewski, AT Reder, R Maselli… - Annals of Neurology …, 1990 - Wiley Online Library
JW Karaszewski, AT Reder, R Maselli, M Brown, BGW Arnason
Annals of Neurology: Official Journal of the American Neurological …, 1990Wiley Online Library
Immune abnormalities, including deficient CD8 lymphocyte‐mediated suppression, have
been implicated in the progression of multiple sclerosis (MS). The peripheral sympathetic
branch of the autonomic nervous system innervates the lymphoid organs and affects
immune function. Animals with an ablated sympathetic nervous system develop more severe
experimental allergic encephalomyelitis than control animals and exhibit an increased
density of betaadrenergic receptors on their lymphocytes. Experimental allergic …
Abstract
Immune abnormalities, including deficient CD8 lymphocyte‐mediated suppression, have been implicated in the progression of multiple sclerosis (MS). The peripheral sympathetic branch of the autonomic nervous system innervates the lymphoid organs and affects immune function. Animals with an ablated sympathetic nervous system develop more severe experimental allergic encephalomyelitis than control animals and exhibit an increased density of betaadrenergic receptors on their lymphocytes. Experimental allergic encephalomyelitis shares many features with MS. Accordingly, we investigated the psychogalvanic skin reflex in patients with rapidly progressive MS and found that 13 patients (57%) lacked this sympathetic‐mediated response. The density of beta‐adrenergic receptors on lymphocyte subsets was increased in progressive MS, most notably on the CD8 suppressor/cytotoxic subset. B lymphocytes had the greatest number of receptors with 12.1 ± 1.8 fmol/106 cells in control subjects and 18.7 ± 2.6 fmol/106 cells in patients with MS. CD8 lymphocytes possessed an intermediate number of receptors with 3.4 ± 0.4 fmol/106 cells in control subjects and 9.1 ± 1.6 fmol/106 cells in patients with MS. CD4 lymphocytes demonstrated the fewest receptors with 1.2 ± 0.1 fmol/106 cells in control subjects and 1.8 ± 0.4 fmol/106 cells in patients with MS. No differences in the affinity or function (cyclic adenosine monophosphate levels in response to 10−5 M (–)isoproterenol) of the adrenergic receptor were found when patients with progressive MS and control subjects were compared. Autonomic abnormalities in progressive MS and the increased beta‐adrenergic receptor density found on CD8 lymphocytes may be related.
Wiley Online Library